Psyence Bio (PBM) Cash Funds per Single Share

Symbol and logo of brand Psyence Bio (PBM)

The analysis of Psyence Biomedical Ltd. (PBM) begins with legal uncertainties in the medical field and regulatory threats. The current liquidity level per share on the precise chart at GURU.Markets reflects capital dynamics, where the 1.87 indicator confirms the current level. Prospects are based on the development of Canadian silver deposits, while long-term catalysts are formed by the exploration of new sites and the assessment of mineral reserves.

Cash per Share: Psyence Biomedical Ltd. (PBM) for 02/21/2024 - 11/20/2026

Comprehensive metric breakdowns and analytics for Psyence Biomedical (PBM)

- market price and analyst price targets:
- cash and cash flow data:
Summary company analysis:Psyence Biomedical Ltd.
Flagship merchandise of pacificbayminerals.com

The metric is calculated by dividing the total volume of liquid assets by the number of shares outstanding. This metric determines the intrinsic value of the security and its resilience to external shocks. The formula's dynamics depend directly on quarterly cash flow statements. An analysis of cash per share demonstrates the financial cushion of Psyence Biomedical Ltd. (PBM) for funding clinical trials of psilocybin drugs. Sufficient capital is critical for the successful registration of the therapy in the US.